The Now and Beyond of Tumor Mutational Burden as a Predictor of Response to Immune Checkpoint Inhibitors [News & Views]

Source: Clinical Chemistry - Category: Chemistry Authors: Tags: News & amp; Views Source Type: research
More News: Chemistry